Role of acupuncture in the management of diabetic painful neuropathy (DPN): a pilot RCT

Painful diabetic neuropathy (PDN) is a debilitating complication of diabetes that affects up to one third of patients with type 2 diabetes, causing severe nocturnal pain, burning, and electric-shock sensations in the feet and legs. Current treatment is based mainly on medications such as tricyclic antidepressants and anticonvulsants, but up to two thirds of patients experience significant side effects, and 15% stop treatment because of these adverse effects. This randomized controlled pilot study investigated whether acupuncture could be a viable and safe alternative for managing PDN. The researchers recruited 59 patients with diabetes and confirmed painful neuropathy from primary and secondary care centers.

Participants were randomized to receive 10 weekly sessions of real acupuncture (24 patients) or sham acupuncture with non-penetrating sham needles (21 patients). The protocol used five standardized acupuncture points in each leg (LR-3, KI-3, SP-6, SP-10, and ST-36), selected based on traditional Chinese medicine principles for diabetes and neuropathy. Three experienced acupuncturists performed the treatments, following rigorous protocols to ensure standardization. The study was carefully designed as single-blind, using validated sham devices to maintain patient blinding.

Primary outcomes were measured with validated scales, including LANSS for neuropathic symptoms, the visual analogue scale (VAS) for pain, the Sleep Problems Scale (SPS), and quality-of-life questionnaires. Forty-five patients completed the study (76% completion rate). The results showed promising improvements in the real acupuncture group compared with the sham group. On the VAS pain scale, the real acupuncture group had a mean reduction of 15 points versus only 5 points in the sham group.

Sleep quality improved significantly, with a 2.5-point reduction on the Sleep Problems Scale in the active group. The MYMOP questionnaire, which measures patient-centered outcomes, showed an improvement of 0.89 points in the real acupuncture group. An interesting finding was a 5.2 mmHg reduction in diastolic blood pressure in the acupuncture group, suggesting additional cardiovascular benefits. Analysis of covariance revealed a moderate treatment effect favoring active acupuncture, with a 2.1-point improvement on the LANSS scale compared with sham.

Approximately 46% of patients in the active group had at least a 25% improvement in pain intensity, compared with only 13% in the sham group. The treatment was very well tolerated, with only three adverse events leading to study withdrawal, none directly related to acupuncture. There were no infections or significant complications. Post hoc analysis of blinding showed that 40% of the active group thought they had received sham treatment and 42% of the sham group thought they had received real acupuncture, indicating adequate blinding.

The clinical implications of this study are significant. It demonstrates that acupuncture can be readily integrated into the routine care of patients with diabetes in specialty clinics. The results suggest that acupuncture may provide symptomatic relief comparable to other treatments for chronic pain, with a safety profile superior to that of conventional medications. The improvement in sleep quality is particularly relevant, as sleep disturbances are common and debilitating in PDN.

The study also identified appropriate outcome measures for larger future studies. Limitations include the small sample size, which limited statistical power to detect significant differences in some measures. The dropout rate was higher in the sham group (47% versus 17%), which could introduce bias. The study was conducted at a single center with a predominantly White British population, limiting generalizability.

In addition, as a feasibility pilot study, it was not designed to be definitive about efficacy. This work establishes a solid foundation for larger definitive studies of acupuncture in PDN. The authors recommend that future research include larger samples, multiple centers, and cost-effectiveness measures. The study adds to the growing evidence that acupuncture may be a valuable therapeutic option for chronic pain conditions in diabetes, offering an alternative or complement to conventional pharmacological treatments.